Oncorheumatology: relationship between malignancies and musculoskeletal diseases
Onkoreumatológia: a daganatos és mozgásszervi kórképek összefüggései
carcinogenicity
carcinogenitas
célzott terápia
daganatok
immuncheckpointgátlók
immune-checkpoint inhibition
mozgásszervi betegségek
musculoskeletal diseases
oncorheumatology
onkoreumatológia
sarcomas
sarcomák
secondary tumour development
szekunder daganatképződés
targeted therapy
tumours
Journal
Orvosi hetilap
ISSN: 1788-6120
Titre abrégé: Orv Hetil
Pays: Hungary
ID NLM: 0376412
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
22
03
2020
accepted:
06
04
2020
entrez:
2
7
2020
pubmed:
2
7
2020
medline:
8
7
2020
Statut:
ppublish
Résumé
Oncorheumatology is the meeting point of tumour formation and rheumatic diseases. Multiple interactions exist between these two medical specialties. One major field is the topic of malignancies associated with rheumatic diseases, while the other topic covers the development of musculoskeletal disease in cancer patients. In the first group, secondary malignancies associated with rheumatic diseases, role of tumour-associated antigens in rheumatology, the possible carcinogenicity of conventional and targeted antirheumatic drugs and physical therapy of rheumatic patients with recent or current cancer will be discussed. The second large topic includes paraneoplastic syndromes, autoimmune-rheumatic side effects of oncotherapies (chemotherapy and immunotherapy), effects of hormone-deprivation therapies on bone and primary and secondary malignancies of the musculoskeletal system. Orv Hetil. 2020; 161(28): 1151-1165.
Identifiants
pubmed: 32609623
doi: 10.1556/650.2020.31800
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Langues
hun
Sous-ensembles de citation
IM